LTRN - Lantern Pharma Inc
IEX Last Trade
3.97
-0.070 -1.763%
Share volume: 26,057
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$4.04
-0.07
-1.73%
Summary score
24%
Profitability
25%
Dept financing
5%
Liquidity
50%
Performance
20%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-33.48%
Return on assets
-18.93%
Return on sales
0%
Return on invested capital
152.65%
Total debt ratio
20.58%
Debt ratio change over timeo
-0.92%
Current Ratio
13.45%
Quick Ratio
0%
Cash Position Ratio
12.42%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-33.48%
Return on assets
-18.93%
Return on sales
0%
Return on invested capital
152.65%
Total debt ratio
20.58%
Debt ratio change over timeo
-0.92%
Current Ratio
13.45%
Quick Ratio
0%
Cash Position Ratio
12.42%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
-7.89%
Return on assets
-7.56%
Return on sales
0%
Return on invested capital
213.5%
Total debt ratio
4.1%
Debt ratio change over time
-0.89%
Current Ratio
27.59%
Quick Ratio
0%
Cash Position Ratio
25.54%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-111.57%
Return on assets
-111.05%
Return on sales
0%
Return on invested capital
198.52%
Total debt ratio
-92.19%
Debt ratio change over time
-0.92%
Current Ratio
39.14%
Quick Ratio
0%
Cash Position Ratio
36.16%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | LTRN | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -33.48% | -3.65% | 12.3% | 6.42% |
| Return on assets | -18.93% | 3.5% | 3.6% | 5.35% |
| Return on sales | 0% | 31.31% | 41.82% | 33.97% |
| Return on invested capital | 152.65% | 4.99% | 7.81% | 13.62% |
| Profitability | 25% | 36% | 68% | 61% |
| Total debt ratio | 20.58% | 101.15% | 75.51% | 29.75% |
| Debt ratio change over time | -0.92% | 224.03% | 6.03% | 1.46% |
| Dept financing | 5% | 50% | 19% | 8% |
| Current Ratio | 13.45% | 2.03% | 1.87% | 3.47% |
| Quick Ratio | 0% | 1.9% | 1.53% | 2.82% |
| Cash Position Ratio | 12.42% | 1.41% | 0.73% | 1.41% |
| Liquididy | 50% | 14% | 33% | 33% |
| Short-term ratios | LTRN | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -33.48% | -16.17% | 18.05% | 7.63% |
| Return on assets | -18.93% | 2.71% | 3.58% | 5.03% |
| Return on sales | 0% | 29.9% | 36.22% | 35.56% |
| Return on invested capital | 152.65% | 6.54% | 5.97% | 19.39% |
| Profitability | 25% | 35% | 69% | 63% |
| Total debt ratio | 20.58% | 99.31% | 83.77% | 30.59% |
| Debt ratio change over time | -0.92% | 851.68% | 10.97% | 0.58% |
| Dept financing | 5% | 50% | 21% | 8% |
| Current Ratio | 13.45% | 2.03% | 1.87% | 3.47% |
| Quick Ratio | 0% | 1.9% | 1.53% | 2.82% |
| Cash Position Ratio | 12.42% | 1.41% | 0.73% | 1.41% |
| Liquididy | 50% | 23% | 19% | 34% |